Identification of genes involved in ceramide-dependent neuronal apoptosis using cDNA arrays

Genome Biology

Volumn 3, Issue 8, 2002, Pages

  Decraene, Charles ^a,d   Brugg, Bernard ^b   Ruberg, Merle ^c   Eveno, Eric ^a   Matingou, Christiane ^a   Tahi, Fariza ^a,e   Mariani, Jean ^b   Auffray, Charles ^a   Pietu, Geneviève ^a,d  

^a CNRS   (France)

^b Groupe Enzymologie Moléculaire et Fonctionnelle   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d CEA Service de Génomique Fonctionnelle   (France)

^e UNIVERSITÉ D EVRY VAL D ESSONNE   (France)

Author keywords

Ceramide; Differentiate PC12 Cell; Effector Phase; PC12 Cell; Spinal Muscular Atrophy

Indexed keywords

DRUG DERIVATIVE; N ACETYLSPHINGOSINE; N-ACETYLSPHINGOSINE; SPHINGOSINE;

ANIMAL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN; CYTOLOGY; DNA MICROARRAY; GENE; GENE EXPRESSION PROFILING; GENETICS; METHODOLOGY; NERVE CELL; NUCLEIC ACID HYBRIDIZATION; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; VALIDATION STUDY;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; GENE EXPRESSION PROFILING; GENES; NEURONS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PC12 CELLS; RATS; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 0037205717     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/gb-2002-3-8-research0042     Document Type: Article

References (85)

1. Hannun YA: Functions of ceramide in coordinating cellular responses to stress. Science. 1996, 274: 1855-1859. 10.1126/science.274.5294.1855. DOI: 10.1126/science.274.5294.1855
2. Mathias S, Pena LA, Kolesnick RN: Signal transduction of stress via ceramide. Biochem J. 1998, 335: 465-480. DOI: 10.1042/bj3350465
3. Furuya S, Mitoma J, Makino A, Hirabayashi Y: Ceramide and its interconvertible metabolite sphingosine function as indispensable lipid factors involved in survival and dendritic differentiation of cerebellar Purkinje cells. J Neurochem. 1998, 71: 366-377. DOI: 10.1046/j.1471-4159.1998.71010366.x
4. Obeid LM, Venable ME: Signal transduction in cellular senescence. J Am Geriatr Soc. 1997, 45: 361-366. DOI: 10.1111/j.1532-5415.1997.tb00954.x
5. Kolesnick R, Golde DW: The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell. 1994, 77: 325-328. DOI: 10.1016/0092-8674(94)90147-3
6. Kyprianou N, Alexander RB, Isaacs JT: Activation of programmed cell death by recombinant human tumor necrosis factor plus topoisomerase II-targeted drugs in L929 tumor cells. J Natl Cancer Inst. 1991, 83: 346-350. DOI: 10.1093/jnci/83.5.346
7. Brugg B, Michel PP, Agid Y, Ruberg M: Ceramide induces apoptosis in cultured mesencephalic neurons. J Neurochem. 1996, 66: 733-739. DOI: 10.1046/j.1471-4159.1996.66020733.x
8. Mitoma J, Ito M, Furuya S, Hirabayashi Y: Bipotential roles of ceramide in the growth of hippocampal neurons: promotion of cell survival and dendritic outgrowth in dose- and developmental stage-dependent manners. J Neurosci Res. 1998, 51: 712-722. 10.1002/(SICI)1097-4547(19980315)51:6<712::AID-JNR5>3.3.CO;2-Q. DOI: 10.1002/(SICI)1097-4547(19980315)51:6<712::AID-JNR5>3.0.CO;2-E
9. Hartfield PJ, Mayne GC, Murray AW: Ceramide induces apoptosis in PC12 cells. FEBS Lett. 1997, 401: 148-152. 10.1016/S0014-5793(96)01460-3. DOI: 10.1016/S0014-5793(96)01460-3
10. France-Lanord V, Brugg B, Michel PP, Agid Y, Ruberg M: Mitochondrial free radical signal in ceramide-dependent apoptosis: a putative mechanism for neuronal death in Parkinson's disease. J Neurochem. 1997, 69: 1612-1621. DOI: 10.1046/j.1471-4159.1997.69041612.x
11. Lambeng N, Michel PP, Brugg B, Agid Y, Ruberg M: Mechanisms of apoptosis in PC12 cells irreversibly differentiated with nerve growth factor and cyclic AMP. Brain Res. 1999, 821: 60-68. 10.1016/S0006-8993(99)01061-6. DOI: 10.1016/S0006-8993(99)01061-6
12. Wolff RA, Dobrowsky RT, Bielawska A, Obeid LM, Hannun YA: Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction. J Biol Chem. 1994, 269: 19605-19609.
13. Reyes JG, Robayna IG, Delgado PS, Gonzalez IH, Aguiar JQ, Rosas FE, Fanjul LF, Galarreta CM: c-Jun is a downstream target for ceramide-activated protein phosphatase in A431 cells. J Biol Chem. 1996, 271: 21375-21380. 10.1074/jbc.271.15.8719. DOI: 10.1074/jbc.271.35.21375
14. Su B, Karin M: Mitogen-activated protein kinase cascades and regulation of gene expression. Curr Opin Immunol. 1996, 8: 402-411. 10.1016/S0952-7915(96)80131-2. DOI: 10.1016/S0952-7915(96)80131-2
15. Willaime S, Vanhoutte P, Caboche J, Lemaigre-Dubreuil Y, Mariani J, Brugg B: Ceramide-induced apoptosis in cortical neurons is mediated by an increase in p38 phosphorylation and not by the decrease in ERK phosphorylation. Eur J Neurosci. 2001, 13: 2037-2046. 10.1046/j.0953-816x.2001.01581.x. DOI: 10.1046/j.0953-816x.2001.01581.x
16. Schubert KM, Scheid MP, Duronio V: Ceramide inhibits protein kinase B/Akt by promoting dephosphorylation of serine 473. J Biol Chem. 2000, 275: 13330-13335. 10.1074/jbc.275.18.13330. DOI: 10.1074/jbc.275.18.13330
17. 2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells. Mol Cell Neurosci. 2000, 15: 156-169. 10.1006/mcne.1999.0813. DOI: 10.1006/mcne.1999.0813
18. Basu S, Bayoumy S, Zhang Y, Lozano J, Kolesnick R: BAD enables ceramide to signal apoptosis via Ras and Raf-1. J Biol Chem. 1998, 273: 30419-30426. 10.1074/jbc.273.46.30419. DOI: 10.1074/jbc.273.46.30419
19. Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M, Faucheux BA, Agid Y, Hirsch EC: Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease. Proc Natl Acad Sci USA. 1997, 94: 7531-7536. 10.1073/pnas.94.14.7531. DOI: 10.1073/pnas.94.14.7531
20. Soares MB, Bonaldo MF, Jelene P, Su L, Lawton L, Efstratiadis A: Construction and characterization of a normalized cDNA library. Proc Natl Acad Sci USA. 1994, 91: 9228-9232. DOI: 10.1073/pnas.91.20.9228
21. Nicholson DW: Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 1999, 6: 1028-1042. 10.1038/sj/cdd/4400598. DOI: 10.1038/sj.cdd.4400598
22. Hartfield PJ, Bilney AJ, Murray AW: Neurotrophic factors prevent ceramide-induced apoptosis downstream of c-Jun N-terminal kinase activation in PC12 cells. J Neurochem. 1998, 71: 161-169. DOI: 10.1046/j.1471-4159.1998.71010161.x
23. Houlgatte R, Mariage-Samson R, Duprat S, Tessier A, Bentolila S, Lamy B, Auffray C: The Genexpress Index: a resource for gene discovery and the genic map of the human genome. Genome Res. 1995, 5: 272-304. DOI: 10.1101/gr.5.3.272
24. Identification of genes involved in ceramide-dependent neuronal apoptosis using cDNA array. [http://idefix.ers1984.vjf.cnrs.fr/APOPTOSE/]
25. Jayadev S, Hayter HL, Andrieu N, Gamard CJ, Liu B, Balu R, Hayakawa M, Ito F, Hannun YA: Phospholipase A2 is necessary for tumor necrosis factor alpha-induced ceramide generation in L929 cells. J Biol Chem. 1997, 272: 17196-17203. 10.1074/jbc.272.27.17196. DOI: 10.1074/jbc.272.27.17196
26. Janes RW, Munroe PB, Mitchison HM, Gardiner RM, Mole SE, Wallace BA: A model for Batten disease protein CLN3: functional implications from homology and mutations. FEBS Lett. 1996, 399: 75-77. 10.1016/S0014-5793(96)01290-2. DOI: 10.1016/S0014-5793(96)01290-2
27. The International Batten Disease Consortium: Isolation of a novel gene underlying Batten disease, CLN3. Cell. 1995, 82: 949-957. DOI: 10.1016/0092-8674(95)90274-0
28. Gilles F, Raes MB, Stehelin D, Vandenbunder B, Fafeur V: The c-ets-1 proto-oncogene is a new early-response gene differentially regulated by cytokines and growth factors in human fibroblasts. Exp Cell Res. 1996, 222: 370-378. 10.1006/excr.1996.0046. DOI: 10.1006/excr.1996.0046
29. Basile A, Sica A, d'Aniello E, Breviario F, Garrido G, Castellano M, Mantovani A, Introna M: Characterization of the promoter for the human long pentraxin PTX3. Role of NF-kappaB in tumor necrosis factor-alpha and interleukin-1beta regulation. J Biol Chem. 1997, 272: 8172-8178. 10.1074/jbc.272.13.8172. DOI: 10.1074/jbc.272.13.8172
30. Mantovani A, Muzio M, Ghezzi P, Colotta C, Introna M: Regulation of inhibitory pathways of the interleukin-1 system. Ann NY Acad Sci. 1998, 840: 338-351. DOI: 10.1111/j.1749-6632.1998.tb09573.x
31. Solis-Herruzo JA, Brenner DA, Chojkier M: Tumor necrosis factor alpha inhibits collagen gene transcription and collagen synthesis in cultured human fibroblasts. J Biol Chem. 1988, 263: 5841-5845.
32. Hernandez-Munoz I, de la Torre P, Sanchez-Alcazar JA, Garcia I, Santiago E, Munoz-Yague MT, Solis-Herruzo JA: Tumor necrosis factor alpha inhibits collagen alpha 1(I) gene expression in rat hepatic stellate cells through a G protein. Gastroenterology. 1997, 113: 625-640. DOI: 10.1053/gast.1997.v113.pm9247485
33. Wolf FW, Marks RM, Sarma V, Byers MG, Katz RW, Shows TB, Dixit VM: Characterization of a novel tumor necrosis factor-alpha-induced endothelial primary response gene. J Biol Chem. 1992, 267: 1317-1326.
34. Bellosta P, Zhang Q, Goff SP, Basilico C: Signaling through the ARK tyrosine kinase receptor protects from apoptosis in the absence of growth stimulation. Oncogene. 1997, 15: 2387-2397. 10.1038/sj/onc/1201419. DOI: 10.1038/sj.onc.1201419
35. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G, Farahani R, McLean M, Ikeda JE, MacKenzie A, Korneluk RG: Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature. 1996, 379: 349-353. 10.1038/379349a0. DOI: 10.1038/379349a0
36. Masuelli L, Ettenberg S, Vasaturo F, Vestergaard-Sykes K, Cutler ML: The ras suppressor, RSU-1, enhances nerve growth factor-induced differentiation of PC12 cells and induces p21CIP expression. Cell Growth Differ. 1999, 10: 555-564.
37. Masuelli L, Cutler ML: Increased expression of the Ras suppressor Rsu-1 enhances Erk-2 activation and inhibits Jun kinase activation. Mol Cell Biol. 1996, 16: 5466-5476. DOI: 10.1128/MCB.16.10.5466
38. Underwood KW, Song C, Kriz RW, Chang XJ, Knopf JL, Lin LL: A novel calcium-independent phospholipase A2, cPLA2-gamma, that is prenylated and contains homology to cPLA2. J Biol Chem. 1998, 273: 21926-21932. 10.1074/jbc.273.34.21926. DOI: 10.1074/jbc.273.34.21926
39. Hoeck WG, Ramesha CS, Chang DJ, Fan N, Heller RA: Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis. Proc Natl Acad Sci USA. 1993, 90: 4475-4479. DOI: 10.1073/pnas.90.10.4475
40. Wu T, Ikezono T, Angus CW, Shelhamer JH: Tumor necrosis factor-alpha induces the 85-kDa cytosolic phospholipase A2 gene expression in human bronchial epithelial cells. Biochim Biophys Acta. 1996, 1310: 175-184. 10.1016/0167-4889(95)00143-3. DOI: 10.1016/0167-4889(95)00143-3
41. Hayakawa M, Jayadev S, Tsujimoto M, Hannun YA, Ito F: Role of ceramide in stimulation of the transcription of cytosolic phospholipase A2 and cyclooxygenase 2. Biochem Biophys Res Commun. 1996, 220: 681-686. 10.1006/bbrc.1996.0464. DOI: 10.1006/bbrc.1996.0464
42. Puranam KL, Guo WX, Qian WH, Nikbakht K, Boustany RM: CLN3 defines a novel antiapoptotic pathway operative in neurode-generation and mediated by ceramide. Mol Genet Metab. 1999, 66: 294-308. 10.1006/mgme.1999.2834. DOI: 10.1006/mgme.1999.2834
43. Xing X, Wang SC, Xia W, Zou Y, Shao R, Kwong KY, Yu Z, Zhang S, Miller S, Huang L, Hung MC: The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis. Nat Med. 2000, 6: 189-195. 10.1038/72294. DOI: 10.1038/72294
44. Nakae K, Nakajima K, Inazawa J, Kitaoka T, Hirano T: ERM, a PEA3 subfamily of Ets transcription factors, can cooperate with c-Jun. J Biol Chem. 1995, 270: 23795-23800. 10.1074/jbc.270.40.23795. DOI: 10.1074/jbc.270.40.23795
45. Basuyaux JP, Ferreira E, Stehelin D, Buttice G: The Ets transcription factors interact with each other and with the c-Fos/ c-Jun complex via distinct protein domains in a DNA-dependent and -independent manner. J Biol Chem. 1997, 272: 26188-26195. 10.1074/jbc.272.42.26188. DOI: 10.1074/jbc.272.42.26188
46. Herdegen T, Leah JD: Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res Brain Res Rev. 1998, 28: 370-490. 10.1016/S0165-0173(98)00018-6. DOI: 10.1016/S0165-0173(98)00018-6
47. Duong T, Nikolaeva M, Acton PJ: C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease. Brain Res. 1997, 749: 152-156. 10.1016/S0006-8993(96)01359-5. DOI: 10.1016/S0006-8993(96)01359-5
48. Duong T, Acton PJ, Johnson RA: The in vitro neuronal toxicity of pentraxins associated with Alzheimer's disease brain lesions. Brain Res. 1998, 813: 303-312. 10.1016/S0006-8993(98)00966-4. DOI: 10.1016/S0006-8993(98)00966-4
49. Allen MP, Zeng C, Schneider K, Xiong X, Meintzer MK, Bellosta P, Basilico C, Varnum B, Heidenreich KA, Wierman ME: Growth arrest-specific gene 6 (Gas6)/adhesion related kinase (Ark) signaling promotes gonadotropin-releasing hormone neuronal survival via extracellular signal-regulated kinase (ERK) and Akt. Mol Endocrinol. 1999, 13: 191-201. DOI: 10.1210/mend.13.2.0230
50. Zhou H, Summers SA, Birnbaum MJ, Pittman RN: Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis. J Biol Chem. 1998, 273: 16568-16575. 10.1074/jbc.273.26.16568. DOI: 10.1074/jbc.273.26.16568
51. Goswami R, Kilkus J, Dawson SA, Dawson G: Overexpression of Akt (protein kinase B) confers protection against apoptosis and prevents formation of ceramide in response to pro-apoptotic stimuli. J Neurosci Res. 1999, 57: 884-893. 10.1002/(SICI)1097-4547(19990915)57:6<884::AID-JNR14>3.3.CO;2-1. DOI: 10.1002/(SICI)1097-4547(19990915)57:6<884::AID-JNR14>3.0.CO;2-A
52. Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, Farahani R, Baird S, Besner-Johnston A, Lefebvre C, Kang X, et al: The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell. 1995, 80: 167-178. DOI: 10.1016/0092-8674(95)90461-1
53. Tsuda T, Marinetti MR, Masuelli L, Cutler ML: The Ras suppressor RSU-1 localizes to 10p13 and its expression in the U251 glioblastoma cell line correlates with a decrease in growth rate and tumorigenic potential. Oncogene. 1995, 11: 397-403.
54. Kajikawa S, Nakayama H, Suzuki M, Takashima A, Murayama O, Nishihara M, Takahashi M, Doi K: Increased expression of rat ribosomal protein L4 mRNA in 5-azacytidine-treated PC12 cells prior to apoptosis. Biochem Biophys Res Commun. 1998, 252: 220-224. 10.1006/bbrc.1998.9633. DOI: 10.1006/bbrc.1998.9633
55. 2+-dependent reaction. J Biol Chem. 1999, 274: 1533-1540. 10.1074/jbc.274.3.1533. DOI: 10.1074/jbc.274.3.1533
56. Vito P, Lacana E, D'Adamio L: Interfering with apoptosis: Ca(2+)-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science. 1996, 271: 521-525. DOI: 10.1126/science.271.5248.521
57. Lacana E, Ganjei JK, Vito P, D'Adamio L: Dissociation of apoptosis and activation of IL-1beta-converting enzyme/Ced-3 proteases by ALG-2 and the truncated Alzheimer's gene ALG-3. J Immunol. 1997, 158: 5129-5135.
58. Kang JX, Bell J, Beard RL, Chandraratna RA: Mannose 6-phosphate/insulin-like growth factor II receptor mediates the growth-inhibitory effects of retinoids. Cell Growth Differ. 1999, 10: 591-600.
59. Degen WG, Weterman MA, van Groningen JJ, Cornelissen IM, Lemmers JP, Agterbos MA, Geurts van Kessel A, Swart GW, Bloemers HP: Expression of nma, a novel gene, inversely correlates with the metastatic potential of human melanoma cell lines and xenografts. Int J Cancer. 1996, 65: 460-465. 10.1002/(SICI)1097-0215(19960208)65:4<460::AID-IJC12>3.0.CO;2-E. DOI: 10.1002/(SICI)1097-0215(19960208)65:4<460::AID-IJC12>3.0.CO;2-E
60. Nakagawa H, Koyama K, Murata Y, Morito M, Akiyama T, Nakamura Y: APCL, a central nervous system-specific homologue of adenomatous polyposis coli tumor suppressor, binds to p53-binding protein 2 and translocates it to the perinucleus. Cancer Res. 2000, 60: 101-105.
61. Ray MK, Datta B, Chakraborty A, Chattopadhyay A, Meza-Keuthen S, Gupta NK: The eukaryotic initiation factor 2-associated 67-kDa polypeptide (p67) plays a critical role in regulation of protein synthesis initiation in animal cells. Proc Natl Acad Sci USA. 1992, 89: 539-543. DOI: 10.1073/pnas.89.2.539
62. Cuddihy AR, Li S, Tam NW, Wong AH, Taya Y, Abraham N, Bell JC, Koromilas AE: Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53. Mol Cell Biol. 1999, 19: 2475-2484. DOI: 10.1128/MCB.19.4.2475
63. Ozaki T, Hanaoka E, Naka M, Nakagawara A, Sakiyama S: Cloning and characterization of rat BAT3 cDNA. DNA Cell Biol. 1999, 18: 503-512. 10.1089/104454999315222. DOI: 10.1089/104454999315222
64. Wang S, Nath N, Fusaro G, Chellappan S: Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals. Mol Cell Biol. 1999, 19: 7447-7460. DOI: 10.1128/MCB.19.11.7447
65. Wang S, Nath N, Adlam M, Chellappan S: Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene. 1999, 18: 3501-3510. 10.1038/sj/onc/1202684. DOI: 10.1038/sj.onc.1202684
66. Matsushima M, Fujiwara T, Takahashi E, Minaguchi T, Eguchi Y, Tsujimoto Y, Suzumori K, Nakamura Y: Isolation, mapping, and functional analysis of a novel human cDNA (BNIP3L) encoding a protein homologous to human NIP3. Genes Chromosomes Cancer. 1998, 21: 230-235. 10.1002/(SICI)1098-2264(199803)21:3<230::AID-GCC7>3.3.CO;2-G. DOI: 10.1002/(SICI)1098-2264(199803)21:3<230::AID-GCC7>3.0.CO;2-0
67. Lee SW: H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat Med. 1996, 2: 776-782. DOI: 10.1038/nm0796-776
68. Lee SW, Reimer CL, Campbell DB, Cheresh P, Duda RB, Kocher O: H-cadherin expression inhibits in vitro invasiveness and tumor formation in vivo. Carcinogenesis. 1998, 19: 1157-1159. 10.1093/carcin/19.6.1157. DOI: 10.1093/carcin/19.6.1157
69. Pegg AE, Wechter RS, Clark RS, Wiest L, Erwin BG: Acetylation of decarboxylated S-adenosylmethionine by mammalian cells. Biochemistry. 1986, 25: 379-384. DOI: 10.1021/bi00350a016
70. Tabor CW, Tabor H: Polyamines. Annu Rev Biochem. 1984, 53: 749-790. 10.1146/annurev.bi.53.070184.003533. DOI: 10.1146/annurev.bi.53.070184.003533
71. Murakami Y, Ichiba T, Matsufuji S, Hayashi S: Cloning of antizyme inhibitor, a highly homologous protein to ornithine decarboxylase. J Biol Chem. 1996, 271: 3340-3342. 10.1074/jbc.271.7.3340. DOI: 10.1074/jbc.271.7.3340
72. Iwata S, Sato Y, Asada M, Takagi M, Tsujimoto A, Inaba T, Yamada T, Sakamoto S, Yata J, Shimogori T, et al: Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation. Oncogene. 1999, 18: 165-172. 10.1038/sj/onc/1202275. DOI: 10.1038/sj.onc.1202275
73. Zhang H, Xu Q, Krajewski S, Krajewska M, Xie Z, Fuess S, Kitada S, Godzik A, Reed JC: BAR: An apoptosis regulator at the intersection of caspases and Bcl-2 family proteins. Proc Natl Acad Sci USA. 2000, 97: 2597-2602. 10.1073/pnas.97.6.2597. DOI: 10.1073/pnas.97.6.2597
74. Zhang L, Himi T, Morita I, Murota S: Hepatocyte growth factor protects cultured rat cerebellar granule neurons from apop-tosis via the phosphatidylinositol-3 kinase/Akt pathway. J Neurosci Res. 2000, 59: 489-496. 10.1002/(SICI)1097-4547(20000215)59:4<489::AID-JNR3>3.3.CO;2-0. DOI: 10.1002/(SICI)1097-4547(20000215)59:4<489::AID-JNR3>3.0.CO;2-9
75. Alsbo CW, Wrang ML, Moller F, Diemer NH: Is the AMPA receptor subunit GluR2 mRNA an early indicator of cell fate after ischemia? A quantitative single cell RT-PCR study. Brain Res. 2001, 894: 101-108. 10.1016/S0006-8993(01)01985-0. DOI: 10.1016/S0006-8993(01)01985-0
76. Li WP, Lai HW, Cheng SY, Yew DT: Somatostatin-positive neurons in the different parts of the brain in normal aging and Alzheimer's disease. Biol Signals. 1996, 5: 343-348. DOI: 10.1159/000109207
77. Lorson CL, Strasswimmer J, Yao JM, Baleja JD, Hahnen E, Wirth B, Le T, Burghes AH, Androphy EJ: SMN oligomerization defect correlates with spinal muscular atrophy severity. Nat Genet. 1998, 19: 63-66. DOI: 10.1038/ng0598-63
78. Narasimhan P, Sklar R, Murrell M, Swanson RA, Sharp FR: Methyl-malonyl-CoA mutase induction by cerebral ischemia and neurotoxicity of mitochondrial toxin methylmalonic acid. J Neurosci. 1996, 22: 7336-7346.
79. Baeuerle PA, Henkel T: Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 1994, 12: 141-179. DOI: 10.1146/annurev.iy.12.040194.001041
80. Greene LA, Tischler AS: Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA. 1976, 73: 2424-2428. DOI: 10.1073/pnas.73.7.2424
81. Michel PP, Vyas S, Agid Y: Synergistic differentiation by chronic exposure to cyclic AMP and nerve growth factor renders rat phaeochromocytoma PC12 cells totally dependent upon trophic support for survival. Eur J Neurosci. 1995, 7: 251-260. DOI: 10.1111/j.1460-9568.1995.tb01061.x
82. GenBank. [http://www.ncbi.nlm.nih.gov/Genbank]
83. Pietu G, Alibert O, Guichard V, Lamy B, Bois F, Leroy E, Mariage-Sampson R, Houlgatte R, Soularue P, Auffray C: Novel gene transcripts preferentially expressed in human muscles revealed by quantitative hybridization of a high density cDNA array. Genome Res. 1996, 6: 492-503. DOI: 10.1101/gr.6.6.492
84. Decraene C, Reguigne-Arnould I, Auffray C, Pietu G: Reverse transcription in the presence of dideoxynucleotides to increase the sensitivity of expression monitoring with cDNA arrays. Biotechniques. 1999, 27: 962-966.
85. UniGene. [http://www.ncbi.nlm.nih.gov/UniGene]